Morepen Labs.

MOREPENLABORATORIES26 Apr 2024

Pharmaceuticals

₹

+0.95 (+1.90%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Morepen Labs.

Morepen Labs.

Pharmaceuticals

MOREPENLABORATORIES26 Apr 2024

₹

+0.95 (+1.90%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
25-Feb-2024	BC	Please find enclosed newspapers advertisements dated 25/02/2024, inter-alia, confirmation of dispatch of notice of Extra-Ordinary General Meeting scheduled to be held on Monday, 18/03/2024 at 11.30 a	18-Mar-2024
19-Feb-2024	BC	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/02/2024 inter alia to consider and approve raising of funds and approval of noti	22-Feb-2024
24-Jan-2024	BC	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve standalone and consolidated unaudited	31-Jan-2024
26-Oct-2023	BC	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve the standalone and consolidated un-au	02-Nov-2023
05-Aug-2023	BC	Unaudited financial results for the quarter ended 30th June 2023 Re-appointment of Mr. Sushil Suri as Chairman & Managing Director of the company with effect from 20 October 2023, for three years.	20-Oct-2023

No Rights has been declared by MOREPENLABORATORIES

Book Closure

Record Date	Split Date	Purpose
18-Mar-2024	-	Please find enclosed newspapers advertisements dated 25/02/2024, inter-alia, confirmation of dispatch of notice of Extra-Ordinary General Meeting scheduled to be held on Monday, 18/03/2024 at 11.30 a
22-Feb-2024	-	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/02/2024 inter alia to consider and approve raising of funds and approval of noti
31-Jan-2024	-	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve standalone and consolidated unaudited
02-Nov-2023	-	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve the standalone and consolidated un-au
20-Oct-2023	-	Unaudited financial results for the quarter ended 30th June 2023 Re-appointment of Mr. Sushil Suri as Chairman & Managing Director of the company with effect from 20 October 2023, for three years.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Morepen Laboratories Ltd ₹51.00(+0.95/1.90%)	51.00	+0.95	2,606.96	87.50	32.06	3.19
Lupin Ltd ₹1,615.95(+21.55/1.35%)	1,615.95	+21.55	73,646.94	128.34	35.73	3.82
Ipca Laboratories Ltd ₹1,338.50(+10.05/0.76%)	1,338.50	+10.05	33,958.31	90.83	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,865.05(+2.25/0.12%)	1,865.05	+2.25	28,944.61	77.48	57.14	10.78
Sanofi India Ltd ₹8,274.15(+120.75/1.48%)	8,274.15	+120.75	19,055.37	38.57	32.28	18.77
IOL Chemicals & Pharmaceuticals Ltd ₹399.50(-0.85/-0.21%)	399.50	-0.85	2,345.28	-2.77	13.60	1.48

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	394.63	381.26	369.10	336.52	344.62	383.34
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	394.63	381.26	369.10	336.52	344.62	383.34
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	3.66	2.84	2.08	2.99	1.19	0.87
Total Income	398.29	384.10	371.19	339.51	345.81	384.22
Total Expenditure	343.52	351.50	344.30	321.39	323.17	356.26
PBIDT	54.77	32.60	26.89	18.12	22.63	27.96
Interest	2.04	0.45	0.28	0.56	0.55	0.47
PBDT	52.73	32.14	26.61	17.56	22.08	27.48
Depreciation	5.51	4.81	4.89	4.61	4.56	4.46
Tax	12.02	7.41	5.86	2.46	4.96	6.50
Deferred Tax	0.00	0.00	0.00	0.20	0.00	0.00
Reported Profit After Tax	35.20	19.92	15.85	10.28	12.57	16.52
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	35.20	19.92	15.85	10.28	12.57	16.52

EPS (Unit Curr.)	0.69	0.39	0.31	0.20	0.23	0.35
EPS (Adj) (Unit Curr.)	0.69	0.39	0.31	0.20	0.23	0.35
Calculated EPS (Unit Curr.)	0.69	0.39	0.31	0.20	0.25	0.32
Calculated EPS (Adj) (Unit Curr.)	0.69	0.39	0.31	0.20	0.25	0.32
Calculated EPS (Ann.) (Unit Curr.)	2.75	1.56	1.24	0.80	0.98	1.29
Calculated EPS (Adj) (Ann.) (Unit Curr.)	2.75	1.56	1.24	0.80	0.98	1.29
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	102.23	102.23	102.23	102.23	102.23	102.23
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	13.88	8.55	7.29	5.38	6.57	7.29
PBDTM(%)	13.36	8.43	7.21	5.22	6.41	7.17
PATM(%)	8.92	5.22	4.29	3.05	3.65	4.31

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	444.55	421.77	401.04	363.69	348.47	402.98
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	444.55	421.77	401.04	363.69	348.47	402.98
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	4.07	3.24	2.42	3.12	1.22	0.87
Total Income	448.62	425.01	403.46	366.81	349.69	403.85
Total Expenditure	393.99	388.18	374.95	348.13	327.95	374.07
PBIDT	54.64	36.83	28.51	18.68	21.74	29.78
Interest	2.17	0.46	0.28	0.56	0.55	0.47
PBDT	52.47	36.37	28.23	18.12	21.19	29.31
Depreciation	8.45	7.69	7.71	6.98	7.19	7.00
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	12.03	7.43	5.88	2.70	5.01	6.50
Deferred Tax	0.00	0.00	0.00	0.20	0.00	0.00
Reported Profit After Tax	31.99	21.26	14.63	8.24	8.99	15.81
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	31.99	21.26	14.63	8.24	8.99	15.81

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	31.99	21.26	14.63	8.24	8.99	15.81

EPS (Unit Curr.)	0.63	0.42	0.29	0.16	0.15	0.33
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	102.23	102.23	102.23	102.23	102.23	102.23

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	12.29	8.73	7.11	5.14	6.24	7.39
PBDTM(%)	11.80	8.62	7.04	4.98	6.08	7.27
PATM(%)	7.20	5.04	3.65	2.27	2.58	3.92

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	102.23	95.56	89.96	89.96	89.96	89.96
Reserves Total	677.89	476.36	311.26	217.29	187.50	160.60
Equity Share Warrants	0.00	26.25	43.75	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	780.12	598.17	444.97	307.25	277.46	250.56
Secured Loans	25.16	18.57	17.05	13.43	10.78	14.12
Unsecured Loans	0.00	0.00	0.00	128.95	128.47	119.65
Total Debt	25.16	18.57	17.05	142.38	139.25	133.77
Total Liabilities	805.28	616.74	462.02	449.63	416.71	384.33
APPLICATION OF FUNDS :
Gross Block	512.07	479.46	516.17	641.52	777.14	890.30
Less : Accumulated Depreciation	341.25	323.35	372.14	506.68	624.55	708.20
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	170.82	156.11	144.03	134.84	152.59	182.10
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	17.01	14.15	1.96	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	117.84	117.79	118.78	118.78	117.72	117.91
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	211.35	258.25	169.61	132.47	90.84	73.94
Sundry Debtors	255.47	221.87	155.52	121.41	121.96	110.22
Cash and Bank	55.90	45.55	66.98	38.03	31.98	5.70
Loans and Advances	208.12	151.09	100.68	56.35	38.52	37.02
Total Current Assets	730.85	676.76	492.79	348.26	283.31	226.89
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	251.83	375.83	355.37	185.67	182.23	189.88
Provisions	14.91	9.61	4.05	2.25	1.14	1.26
Total Current Liabilities	266.74	385.44	359.42	187.92	183.37	191.14
Net Current Assets	464.11	291.33	133.38	160.34	99.94	35.75
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	9.57	9.18	0.00	0.00	0.00	0.00
Deferred Tax Liability	12.26	11.67	0.00	0.00	0.00	0.00
Net Deferred Tax	-2.69	-2.49	0.00	0.00	0.00	0.00
Total Assets	767.09	576.89	398.14	413.96	370.25	335.76
Contingent Liabilities	6.66	1.64	0.93	1.27	11.52	26.07

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	102.23	95.56	89.96	89.96	89.96	89.96
Reserves Total	650.68	456.75	291.04	194.10	163.13	135.98
Equity Share Warrants	0.00	26.25	43.75	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	752.91	578.56	424.75	284.06	253.09	225.94
Minority Interest	-0.46	-0.46	-0.46	-0.46	-0.46	-0.45
Secured Loans	25.16	18.57	17.05	133.12	131.60	134.22
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	25.16	18.57	17.05	133.12	131.60	134.22
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	33.26	31.69	29.23	27.50	21.55	17.25
Total Liabilities	810.87	628.36	470.57	444.22	405.78	376.96
APPLICATION OF FUNDS :
Gross Block	656.24	613.25	628.32	752.55	887.76	997.60
Less: Accumulated Depreciation	389.27	361.45	403.79	536.18	651.55	733.31
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	266.97	251.80	224.53	216.37	236.21	264.29
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	17.01	14.15	1.96	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	1.09	1.09	0.02	0.22
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	228.89	275.85	175.33	138.48	94.20	76.89
Sundry Debtors	263.25	250.64	181.98	137.68	133.75	121.85
Cash and Bank	56.31	45.97	67.89	38.88	32.21	5.95
Loans and Advances	207.73	161.84	101.59	57.14	39.29	38.53
Total Current Assets	756.16	734.31	526.79	372.18	299.45	243.22
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	280.69	426.97	382.33	216.53	208.02	207.52
Provisions	16.24	12.24	5.25	2.72	1.39	1.33
Total Current Liabilities	296.93	439.21	387.58	219.25	209.40	208.85
Net Current Assets	459.24	295.10	139.21	152.93	90.04	34.37
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	9.57	9.18	0.00	0.00	0.00	0.00
Deferred Tax Liability	12.26	11.67	0.00	0.00	0.00	0.00
Net Deferred Tax	-2.69	-2.49	0.00	0.00	0.00	0.00
Other Assets	70.34	69.81	103.79	73.83	79.50	78.07
Total Assets
Contingent Liabilities	6.66	2.64	0.93	1.27	11.52	26.07

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	15.38	40.47	12.79	9.36	5.47
Net Cash from Operating Activities	-102.12	-68.87	49.31	10.86	14.58
Net Cash Used In Investing Activities	-36.20	-22.64	-69.09	-12.08	-10.34
Net Cash Used In Financing Activities	144.20	66.41	47.46	4.65	-0.35
Net Inc./Dec In Cash And Cash Equivalents	5.88	-25.09	27.68	3.43	3.89
Cash And Cash Equivalents At End Of The Year	21.26	15.38	40.47	12.79	9.36

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

38.22%

FII Shareholding

1.85%

DII Shareholding

2.16%

Public Shareholding

57.77%

**Promoter pledged shareholding 38.22%

About Morepen Laboratories Ltd

Morepen Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 2605.94 crores. It has reported a sales of Rs. 394.63 crores and a net profit of Rs. 35.2 crores for the quarter ended December 2018. The company management includes Sushil Suri, Sushil Suri,Manoj Joshi,Bhupender Raj Wadhwa,Sukhcharan singh,Vipul Kumar Srivatava,Sanjay Suri,Praveen Kumar Dutt,Savita (Morepen Laboratories Ltd) among others.

Chairman

Sushil Suri

Registered office

Morepen Village,Nalagarh Road Near Baddi,Solan,Himachal Pradesh,173205

FAX :91-01795-276204

Background

Incorporation Year1984

Face Value₹2

Market Lot1

How to buy Morepen Labs. shares on nse?

To buy Morepen Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Morepen Labs. share price today?

The Morepen Labs. shares price on nse is Rs.51 today.

What is the market cap of Morepen Labs. shares on NSE ?

The company has a market capitalization of Rs.2606.96Cr

What is the PE & PB ratio of Morepen Labs. shares ?

PE is 32.06 and PB is 3.19

What is the 52 Week High and Low of Morepen Labs. shares?

Morepen Labs. stock price high: Rs.56.4 Morepen Labs. stock price low: Rs.25.1